Cargando…
Peptide-Based Vaccination Therapy for Rheumatic Diseases
Rheumatic diseases are extremely heterogeneous diseases with substantial risks of morbidity and mortality, and there is a pressing need in developing more safe and cost-effective treatment strategies. Peptide-based vaccination is a highly desirable strategy in treating noninfection diseases, such as...
Autores principales: | Wang, Bin, Chen, Shiju, Zheng, Qing, Liu, Yuan, Shi, Guixiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104265/ https://www.ncbi.nlm.nih.gov/pubmed/32258176 http://dx.doi.org/10.1155/2020/8060375 |
Ejemplares similares
-
The Role of IL-33 in Rheumatic Diseases
por: Duan, Lihua, et al.
Publicado: (2013) -
Immunological Changes in Peripheral Blood of Ankylosing Spondylitis Patients during Anti-TNF-α Therapy and Their Correlations with Treatment Outcomes
por: Chen, Rongjuan, et al.
Publicado: (2021) -
Associations of Platelet Count with Inflammation and Response to Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis
por: Qian, Hongyan, et al.
Publicado: (2020) -
Efficiency of Therapeutic Plasma-Exchange in Acute Interstitial Lung Disease, Associated With Polymyositis/Dermatomyositis Resistant to Glucocorticoids and Immunosuppressive Drugs: A Retrospective Study
por: Ning, Yaogui, et al.
Publicado: (2019) -
ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases
por: Liu, Yuan, et al.
Publicado: (2021)